NAD+ 1G & TIRZEPATIDE - A UK UPDATE

NAD+ 1g & Tirzepatide - A UK Update

The recent landscape of metabolic health in the UK is seeing significant interest in the pairing of high-dose Nicotinamide Adenine Dinucleotide supplementation – often at 1g dosage – and the novel GLP-1 receptor agonist Retatrutide (or its related Tirzepatide). Specialists are observing potential

read more


Potential Weight Reduction Hope?

Retatrutide is attracting considerable interest as a innovative treatment for weight issues . This groundbreaking medication, developed by the company , represents a major advance in weight control therapies. It works by acting like two website gut

read more